stockrowRevolution Medicines, Inc.
RVMD Healthcare Biotechnology
Revolution Medicines, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $11.6 million, down 67.3% from fiscal 2022.
- Revenue
- +1,188.7%
- EPS
- −18.0%
- Free cash flow
- −99.1%
- Total debt
- +322.7%
Quarter to September 2026, against a year earlier
Follow RVMD
Alert me
Revolution Medicines, Inc. (RVMD) Net margin
Revolution Medicines, Inc.'s net margin over the twelve months to 30 September 2026 was −894.4%, down 894.4 percentage points from fiscal 2025 (0.00%). Over the past ten years it has ranged from −3,768.3% (fiscal 2023) to 0.00% (fiscal 2025) — the current reading is the highest in ten years. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 0.00% | 0.00 |
| FY2024 | 0.00% | 3,768.28 |
| FY2023 | −3,768.3% | (3,065.33) |
| FY2022 | −703.0% | (66.37) |
| FY2021 | −636.6% | (379.79) |
| FY2020 | −256.8% | (133.09) |
| FY2019 | −123.7% | 118.40 |
| FY2018 | −242.1% | (242.10) |
| FY2017 | 0.00% | — |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Sep 2026 | −206.3% | (206.25) |
| Jun 2026 | 0.00% | 0.00 |
| Mar 2026 | 0.00% | 0.00 |
| Dec 2025 | 0.00% | 0.00 |
| 27 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| ARGX argenex SE compare | 31.7% |
| GMAB Genmab A/S Sponsored ADR compare | 19.1% |
| ONC BeOne Medicines Ltd. - Sponsored ADR compare | 13.9% |
| INCY Incyte Corporation compare | 6.71% |
| RPRX Royalty Pharma PLC compare | 0.00% |
| INSM Insmed, Inc. compare | −39.9% |
| BNTX BioNTech SE Sponsored ADR compare | −63.8% |
| RVMD Revolution Medicines, Inc. | −894.4% |
| ROIV Roivant Sciences Ltd. compare | −3,535.0% |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on RVMD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement